Dividendos de Ocumension Therapeutics
Dividendo controles de criterios 0/6
Ocumension Therapeutics does not have a record of paying a dividend.
Información clave
n/a
Rentabilidad por dividendo
0.07%
Rendimiento de la recompra
Rendimiento total para el accionista | 0.07% |
Rendimiento futuro de los dividendos | 0% |
Crecimiento de los dividendos | n/a |
Próxima fecha de pago de dividendos | n/a |
Fecha ex dividendo | n/a |
Dividendo por acción | n/a |
Ratio de pago | n/a |
Últimas actualizaciones de dividendos
No hay actualizaciones
Recent updates
With Ocumension Therapeutics (HKG:1477) It Looks Like You'll Get What You Pay For
Sep 21Analysts Are Upgrading Ocumension Therapeutics (HKG:1477) After Its Latest Results
Aug 15We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Ocumension Therapeutics' (HKG:1477) CEO For Now
Jun 13Ocumension Therapeutics' (HKG:1477) P/S Still Appears To Be Reasonable
Apr 29Here's Why We're Not Too Worried About Ocumension Therapeutics' (HKG:1477) Cash Burn Situation
Mar 14Some Analysts Just Cut Their Ocumension Therapeutics (HKG:1477) Estimates
Aug 29We're Hopeful That Ocumension Therapeutics (HKG:1477) Will Use Its Cash Wisely
Jul 13Is Ocumension Therapeutics (HKG:1477) Trading At A 48% Discount?
Jun 02We're Not Very Worried About Ocumension Therapeutics' (HKG:1477) Cash Burn Rate
Jan 20We're Not Very Worried About Ocumension Therapeutics' (HKG:1477) Cash Burn Rate
Sep 27Could The Ocumension Therapeutics (HKG:1477) Ownership Structure Tell Us Something Useful?
Jan 23Estabilidad y crecimiento de los pagos
Obteniendo datos sobre dividendos
Dividendo estable: Insufficient data to determine if 1477's dividends per share have been stable in the past.
Dividendo creciente: Insufficient data to determine if 1477's dividend payments have been increasing.
Rentabilidad por dividendo vs. Mercado
Rentabilidad por dividendo de Ocumension Therapeutics vs. Mercado |
---|
Segmento | Rentabilidad por dividendo |
---|---|
Empresa (1477) | n/a |
Suelo de mercado 25% (HK) | 3.2% |
Techo de mercado 25% (HK) | 7.9% |
Media de la industria (Pharmaceuticals) | 3.7% |
Analista de previsiones (1477) (hasta 3 años) | 0% |
Dividendo destacado: Unable to evaluate 1477's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Alto dividendo: Unable to evaluate 1477's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Pago de beneficios a los accionistas
Cobertura de los beneficios: Insufficient data to calculate 1477's payout ratio to determine if its dividend payments are covered by earnings.
Pago en efectivo a los accionistas
Cobertura de flujo de caja: Unable to calculate sustainability of dividends as 1477 has not reported any payouts.